← Leaderboards
Christina A Minami
Brigham And Women'S Hospital
$258,000
Attributed
$258,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $129K · FY2021–22$200K$150K$100K$50K$0
'21
'22
Funding mix
By agency
NIH$258,000 · 1
By mechanism
R03$258,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Bethany Hedt-Gauthier$3,339,535
- Jean Claire Lee$9,102,521
- Arthur O Tzianabos$3,638,400
- Gerald B Pier$23,267,480
- Nancy Haff$977,127
Others in their field
Other Emerging Leaders on “American Society Of Clinical Oncology”
- Elizabeth David Kantor · Sloan-Kettering Inst Can Research$3,993,479
- Aniket A Kawatkar · Kaiser Foundation Research Institute$3,505,354
- Jose Alejandro Rauh-Hain · University Of Tx Md Anderson Can Ctr$3,173,942
- Lisa Zubkoff · University Of Alabama At Birmingham$3,039,065
- Veena Shankaran · Fred Hutchinson Cancer Research Center$3,029,954
- Andrew Mizisin · Winsantor, Inc.$2,295,970
Research focus
American Society Of Clinical OncologyAwardAxillaAxillary Lymph Node GroupBaseBreastBreast Cancer TreatmentBreast-Conserving SurgeryCareerCaringChronic PainClinical EncounterComplexConsumptionData SetDecision MakingDesignDiagnosisDiscourse AnalysisElderlyEvaluationFaceFoundationsAffect
Grant awards (2)
Locoregional Treatment Decision-making in Older Adults with Early-Stage, Hormone Receptor-Positive Breast Cancer$129,000
R03 · FY2022 · AG · contact PI
Locoregional Treatment Decision-making in Older Adults with Early-Stage, Hormone Receptor-Positive Breast Cancer$129,000
R03 · FY2021 · AG · contact PI